Related references
Note: Only part of the references are listed.The Association between Metabolic Syndrome and Multiple Myeloma
Sophie C. Ragbourne et al.
ACTA HAEMATOLOGICA (2021)
The mevalonate pathway is an actionable vulnerability oft(4;14)-positive multiple myeloma
Joseph Longo et al.
LEUKEMIA (2021)
Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
Shaojie Wu et al.
FRONTIERS IN ONCOLOGY (2021)
A prognostic survival model based on metabolism-related gene expression in plasma cell myeloma
Han-ying Huang et al.
LEUKEMIA (2021)
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
M. Heider et al.
MOLECULAR CELL (2021)
Metabolic Changes Are Associated with Melphalan Resistance in Multiple Myeloma
David C. Koomen et al.
JOURNAL OF PROTEOME RESEARCH (2021)
Mitochondrial TCA cycle metabolites control physiology and disease
Inmaculada Martinez-Reyes et al.
NATURE COMMUNICATIONS (2020)
Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer
Min Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Challenges and Strategies in the Management of Multiple Myeloma in the Elderly Population
Saurabh Zanwar et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
Claire Gourzones et al.
CANCERS (2019)
Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
Xingzhe Ma et al.
CELL METABOLISM (2019)
Current status of autologous stem cell transplantation for multiple myeloma
Rama Al Hamed et al.
BLOOD CANCER JOURNAL (2019)
IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma
Phyllis S. Y. Chong et al.
CANCER RESEARCH (2019)
Relapsed refractory multiple myeloma: a comprehensive overview
Abdul Hamid Bazarbachi et al.
LEUKEMIA (2019)
Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T cell Function against Multiple Myeloma Is Enhanced in the Presence of Lenalidomide
Melissa Works et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story
Rand Naffouje et al.
CANCERS (2019)
Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma
Reeder M. Robinson et al.
LEUKEMIA (2019)
Multiple Myeloma and Fatty Acid Metabolism
Majdi Masarwi et al.
JBMR PLUS (2019)
A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis
Lenka Besse et al.
HAEMATOLOGICA (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Immunopathogenesis and immunotherapy of multiple myeloma
Hideto Tamura
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Metabolic Features of Multiple Myeloma
Chaima El Arfani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016
Craig M. Hales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma
Zhihong Zheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer
Gregory Noel et al.
SEMINARS IN CANCER BIOLOGY (2018)
Spatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation
Sharanya Sivanand et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
Targeting Tumor Metabolism: A New Challenge to improve immunotherapy
Soumaya Kouidhi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)
Masturah Bte Mohd Abdul Rashid et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Metabolic and Transcriptional Modules Independently Diversify Plasma Cell Lifespan and Function
Wing Y. Lam et al.
CELL REPORTS (2018)
Short overview on the current standard of treatment in newly diagnosed multiple myeloma
Ella Willenbacher et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2018)
Adipose, Bone, and Myeloma: Contributions from the Microenvironment
Michelle M. McDonald et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myeloma
Petra Schneiderova et al.
ONCOTARGET (2017)
Development of GLUT4-selective antagonists for multiple myeloma therapy
Changyong Wei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Targeting adenosine in cancer immunotherapy: a review of recent progress
Theresa L. Whiteside
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes
Katrina E. Allison et al.
IMMUNOLOGY (2017)
PRL-3 improves colorectal cancer cell proliferation and invasion through IL-8 mediated glycolysis metabolism
Heyang Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Modulating the therapeutic response of tumours to dietary serine and glycine starvation
Oliver D. K. Maddocks et al.
NATURE (2017)
The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy
Naoki Hosen et al.
NATURE MEDICINE (2017)
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Michel Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
C. C. Wong et al.
ONCOGENE (2017)
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells
Ravyn M. Thompson et al.
ONCOTARGET (2017)
High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma
Yan Gu et al.
ONCOTARGET (2017)
Extracellular matrix protein Reelin promotes myeloma progression by facilitating tumor cell proliferation and glycolysis
Xiaodan Qin et al.
SCIENTIFIC REPORTS (2017)
Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche
Antonella Chillemi et al.
FRONTIERS IN IMMUNOLOGY (2017)
Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion
Yongyong Yang et al.
PLOS ONE (2017)
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab
Jakub Krejcik et al.
CLINICAL CANCER RESEARCH (2017)
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming
Pu-Ste Liu et al.
NATURE IMMUNOLOGY (2017)
Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
Esther A. Zaal et al.
CANCER & METABOLISM (2017)
Dysfunctional T cell metabolism in the tumor microenvironment
Kathryn E. Beckermann et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
Myeloma today: Disease definitions and treatment advances
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2016)
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells
Paola Storti et al.
HAEMATOLOGICA (2016)
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells
Paola Storti et al.
HAEMATOLOGICA (2016)
MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma
Ya-Wei Qiang et al.
BLOOD (2016)
Metabolic Heterogeneity in Human Lung Tumors
Christopher T. Hensley et al.
CELL (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Omkar U. Kawalekar et al.
IMMUNITY (2016)
The importance of serine metabolism in cancer
Katherine R. Mattaini et al.
JOURNAL OF CELL BIOLOGY (2016)
Statins Are Associated With Reduced Mortality in Multiple Myeloma
Kristen Marie Sanfilippo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity
Ruth Eichner et al.
NATURE MEDICINE (2016)
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
M. A. Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Body Fatness and Cancer - Viewpoint of the IARC Working Group
Beatrice Lauby-Secretan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
K. K. Starheim et al.
BLOOD CANCER JOURNAL (2016)
The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells
Tobias S. Slordahl et al.
ONCOTARGET (2016)
Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation
Eoin McDonnell et al.
CELL REPORTS (2016)
A Metabolic immune Checkpoint: Adenosine in Tumor Microenvironment
Akio Ohta
FRONTIERS IN IMMUNOLOGY (2016)
Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells
Carolyne Falank et al.
FRONTIERS IN ENDOCRINOLOGY (2016)
The unfolded protein response and cellular senescence. A Review in the Theme: Cellular Mechanisms of Endoplasmic Reticulum Stress Signaling in Health and Disease
Olivier Pluquet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress
Zachary T. Schug et al.
CANCER CELL (2015)
Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
Patricia Maiso et al.
CANCER RESEARCH (2015)
Acetyl-CoA and the regulation of metabolism: mechanisms and consequences
Lei Shi et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Long-Lived Plasma Cells Are Contained within the CD19-CD38hiCD138+ Subset in Human Bone Marrow
Jessica L. Halliley et al.
IMMUNITY (2015)
Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance
Yunhua He et al.
LEUKEMIA RESEARCH (2015)
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
Dohoon Kim et al.
NATURE (2015)
Targeting mitochondria metabolism for cancer therapy
Samuel E. Weinberg et al.
NATURE CHEMICAL BIOLOGY (2015)
Modulation of Cell Metabolic Pathways and Oxidative Stress Signaling Contribute to Acquired Melphalan Resistance in Multiple Myeloma Cells
Kamila Anna Zub et al.
PLOS ONE (2015)
Dysregulated metabolism contributes to oncogenesis
Matthew D. Hirschey et al.
SEMINARS IN CANCER BIOLOGY (2015)
Epigenetic treatment of solid tumours: a review of clinical trials
Clara Nervi et al.
CLINICAL EPIGENETICS (2015)
Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study
Su-Hsin Chang et al.
LANCET HAEMATOLOGY (2015)
Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin
Sevim Dalva-Aydemir et al.
CLINICAL CANCER RESEARCH (2015)
Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1
Shiho Fujiwara et al.
EXPERIMENTAL HEMATOLGY & ONCOLOGY (2015)
The skinny on obesity and plasma cell myeloma: a review of the literature
K. R. Carson et al.
BONE MARROW TRANSPLANTATION (2014)
Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies
Lauren R. Teras et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases
Tomoyuki Mashimo et al.
CELL (2014)
Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation
Joyce V. Lee et al.
CELL METABOLISM (2014)
Bone Marrow Adipose Tissue Is an Endocrine Organ that Contributes to Increased Circulating Adiponectin during Caloric Restriction
William P. Cawthorn et al.
CELL METABOLISM (2014)
Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients
A. Busch et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
Roland Nilsson et al.
NATURE COMMUNICATIONS (2014)
Body Mass Index and Physical Activity at Different Ages and Risk of Multiple Myeloma in the NIH-AARP Diet and Health Study
Jonathan N. Hofmann et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
Guellue Topal Goerguen et al.
BLOOD (2013)
Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib
W. Y. Sanchez et al.
BRITISH JOURNAL OF CANCER (2013)
Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration
Zhiwen Liu et al.
CANCER BIOLOGY & THERAPY (2013)
Lactate Dehydrogenase A in Cancer: A Promising Target for Diagnosis and Therapy
Ping Miao et al.
IUBMB LIFE (2013)
Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during Myelomagenesis
Christoph J. Heuck et al.
JOURNAL OF IMMUNOLOGY (2013)
Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment
Tingting Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Establishment of a system for monitoring endoplasmic reticulum redox state in mammalian cells
Kohsuke Kanekura et al.
LABORATORY INVESTIGATION (2013)
Serine, glycine and one-carbon units: cancer metabolism in full circle
Jason W. Locasale
NATURE REVIEWS CANCER (2013)
A prospective study of circulating adipokine levels and risk of multiple myeloma
Jonathan N. Hofmann et al.
BLOOD (2012)
Combined targeting of MEK/MAPK and PI3K/Akt signalling in multiple myeloma
Torsten Steinbrunn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Mariia O. Yuneva et al.
CELL METABOLISM (2012)
The Role of Adiponectin in Cancer: A Review of Current Evidence
Maria Dalamaga et al.
ENDOCRINE REVIEWS (2012)
Elucidation of Acid-induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc
Ramil F. Latypov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Mechanism of Guanine Alkylation by Nitrogen Mustards: A Computational Study
Abhigna Polavarapu et al.
JOURNAL OF ORGANIC CHEMISTRY (2012)
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
A. Lopez-Girona et al.
LEUKEMIA (2012)
Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation
Jose Manuel Tirado-Velez et al.
PLOS ONE (2012)
Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation
Mohit Jain et al.
SCIENCE (2012)
PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Katarzyna Guzinska-Ustymowicz et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
The Metastasis-Promoting Phosphatase PRL-3 Shows Activity toward Phosphoinositides
Victoria McParland et al.
BIOCHEMISTRY (2011)
Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma
Ioanna Papandreou et al.
BLOOD (2011)
Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease
Jessica A. Fowler et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Body mass index and risk of multiple myeloma: A meta-analysis of prospective studies
Alice Wallin et al.
EUROPEAN JOURNAL OF CANCER (2011)
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
Guellue Goerguen et al.
BLOOD (2010)
PCBP1 Suppresses the Translation of Metastasis-Associated PRL-3 Phosphatase
Haihe Wang et al.
CANCER CELL (2010)
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents
Evangelos Terpos et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
PRL-3 Phosphatase and Cancer Metastasis
Abdul Qader O. Al-Aidaroos et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study
Maria Dalamaga et al.
CANCER CAUSES & CONTROL (2009)
PID: the Pathway Interaction Database
Carl F. Schaefer et al.
NUCLEIC ACIDS RESEARCH (2009)
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells
Unn-Merete Fagerli et al.
BLOOD (2008)
Cyclic AMP in rat ileum: Evidence for the presence of an extracellular cyclic AMP-adenosine pathway
Maria Cecilia Giron et al.
GASTROENTEROLOGY (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation
Metin Kurtoglu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells
Philipp Baumann et al.
EXPERIMENTAL CELL RESEARCH (2007)
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib
George Mulligan et al.
BLOOD (2007)
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia
Xianhua Cao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Antibody structure, instability, and formulation
Wei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth
Cheryl A. Doughty et al.
BLOOD (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes
KM Ajuwon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma
M Mattioli et al.
ONCOGENE (2005)
Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions
JC Maher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
EM Hurt et al.
CANCER CELL (2004)
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (Cellcept) in advanced multiple myeloma patients
N Takebe et al.
CLINICAL CANCER RESEARCH (2004)
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells
AH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
T Hideshima et al.
BLOOD (2003)
Share Paper
